Analyst Coverage
Toggle navigation
Toggle navigation
English
中文
Home
Our Company
Our approach
Board of Directors
Management Team
Join us
Developing science
Live Biotherapeutics
MicroRx
MicroDx
Pipeline
Intellectual Property
Delivering therapies
Clinical Development
Manufacturing
Regulatory
Our Collaborations
Clinical
Our Clinical Trials
For Patients
For Clinicians
Newsroom
Press Releases
Events
Posters & Publications
Video & Audio
In The News
Investors
Reports & Presentations
Regulatory News
SEC Filings
RNS Email Alerts
Shareholder Information
Stock Information
Financial Calendar
Corporate Governance
QCA Code Compliance
AIM Rule 26
Analyst Coverage
US Listing Resources
Joint Administrators' Proposals
4d
Our Company
Our approach
Board of Directors
Management Team
Join us
developing-science
Developing science
Live Biotherapeutics
MicroRx
MicroDx
Pipeline
Intellectual Property
delivering-therapies
Delivering therapies
Clinical Development
Manufacturing
Regulatory
Our Collaborations
clinical-trials
Clinical
Our Clinical Trials
For Patients
For Clinicians
Newsroom
Press Releases
Events
Posters & Publications
Video & Audio
In The News
investors
Investors
Reports & Presentations
Regulatory News
SEC Filings
RNS Email Alerts
Shareholder Information
Stock Information
Financial Calendar
Corporate Governance
QCA Code Compliance
AIM Rule 26
Analyst Coverage
US Listing Resources
Joint Administrators' Proposals
Home
Contact
Join us
LinkedIn
Home
Investors
Analyst Coverage
Chardan
Keay Nakae
Ladenburg, Thalmann & Co.
Michael Higgins
Singer Capital Markets
Karl Kegan
Bryan, Garnier & Co.
Olga Smolentseva
BACK TO TOP
